Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2017-02-01
2020-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Clinical Efficacy of Midline Catheters
NCT03457259
Clinical Evaluation of the PowerGlide™ Pro Midline Catheter
NCT06037525
Central Venous Access Device Removal in Cancer Patients
NCT03855969
Midline Catheter and Its Impact on Central Lines Removal in ICU
NCT03675711
Study of the Impact of Frequency of Changing PICCline Dressings in Patients With Acute Leukemia
NCT05793801
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Prior to insertion of the catheter, the study subjects were fully informed and signed the informed consent with participation in the study.
Local signs of inflammation were recorded in the study subjects, together with basic demographic characteristics (age, sex, diagnosis), and complications during catheter insertion, the number of days when the Midline catheter was inserted, number of changes of the dressings, presence of neutropenia in the study subjects and the score of local inflammation according to Madonna.
* Degree 0- no pain or reaction in the surrounding
* Degree 1 - pain only, no reaction in the surrounding
* Degree 2 - pain and reddening
* Degree 3 - pain, reddening, swelling or painful stripe along the vein
* Degree 4 - puss, swelling, reddening and painful stripe along the vein The investigators also observed on which day the first signs of infection appeared.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Neutropenia patients, Dept. of Haematooncology
Patients with neutropenia from the Department of Haematooncology were included in this group.
Midline catheter
Midline catheter is used for administration of intravenous therapy, and is inserted in a larger vein.
No neutropenia patients, Dept. of Haematooncology
Patients without neutropenia from the Department of Haematooncology were included in this group.
Midline catheter
Midline catheter is used for administration of intravenous therapy, and is inserted in a larger vein.
No neutropenia patients, other clinical depts.
Patients with neutropenia from the other clinical departments of the University Hospital Ostrava were included in this group.
Midline catheter
Midline catheter is used for administration of intravenous therapy, and is inserted in a larger vein.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Midline catheter
Midline catheter is used for administration of intravenous therapy, and is inserted in a larger vein.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age over 18 years
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Ostrava
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kateřina Hašová, Mgr.
Role: PRINCIPAL_INVESTIGATOR
University Hospital Ostrava
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Ostrava
Ostrava-Poruba, Czech Republic, Czechia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RVO-FNOs/2017
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
KHO-02-Midline
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.